Neil S. Belloff
General Counsel chez ACORDA THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Postes actifs de Neil S. Belloff
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ACORDA THERAPEUTICS, INC. | General Counsel | 08/11/2021 | - |
| Corporate Secretary | 01/06/2022 | - |
Historique de carrière de Neil S. Belloff
Anciens postes connus de Neil S. Belloff
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Chief Operating Officer | 01/02/2020 | 25/08/2021 |
| General Counsel | 18/06/2018 | 25/08/2021 | |
| Corporate Secretary | 18/06/2018 | 25/08/2021 | |
| CELGENE | Corporate Officer/Principal | 01/01/2011 | - |
| DEUTSCHE TELEKOM AG | Corporate Officer/Principal | - | - |
Formation de Neil S. Belloff
| Queens College | Undergraduate Degree |
| New York University | Graduate Degree |
| Quinnipiac University School of Law | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Allemagne | 2 |
Opérationnelle
| General Counsel | 2 |
| Corporate Secretary | 2 |
| Graduate Degree | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
| Communications | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| DEUTSCHE TELEKOM AG | Communications |
| ACORDA THERAPEUTICS, INC. | Health Technology |
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Bourse
- Insiders
- Neil S. Belloff
- Expérience
